The pivotal genes AAMDC, GPR158, RAD9A, STOML1and STRA13 identified in this study have the potential to serve as molecular therapeutic or immunotherapeutic targets for toxoplasmosis; however, their specific function mechanisms require further verification. This evidence concerns the gene AAMDC and toxoplasmosis.